Engstrom, P F <br/><br/>
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).  [electronic resource] 

 -  American journal of clinical oncology  Aug 1984 
 - 313-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Clinical Trials as Topic<br/>Colonic Neoplasms--drug therapy<br/>Dacarbazine--therapeutic use<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gastrointestinal Diseases--chemically induced<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Hydroxyurea--therapeutic use<br/>Male<br/>Middle Aged<br/>Mitomycins--therapeutic use<br/>Random Allocation<br/>Razoxane--therapeutic use<br/>Rectal Neoplasms--drug therapy<br/>Semustine--therapeutic use<br/>Time Factors